ArticleJAMA2020

Lack of Clinical Benefit of Interferon β-1a Among Patients With Severe Acute Respiratory Distress Syndrome: Time to Overhaul Drug Trials in ARDS?

Manu Shankar-Hari et al.PubMed ↗Publisher ↗

No numbers read from the abstract.